R1 Rcm Inc (RCM)

$13.43

+0.12

(+0.9%)

Market is closed - opens 7 PM, 24 Jul 2024

Performance

  • $13.25
    $13.47
    $13.43
    downward going graph

    1.34%

    Downside

    Day's Volatility :1.6%

    Upside

    0.26%

    downward going graph
  • $8.87
    $18.54
    $13.43
    downward going graph

    33.95%

    Downside

    52 Weeks Volatility :52.16%

    Upside

    27.56%

    downward going graph

Returns

PeriodR1 Rcm IncSector (Health Care)Index (Russel 2000)
3 Months
13.28%
5.3%
0.0%
6 Months
27.61%
6.3%
0.0%
1 Year
-19.14%
9.2%
0.0%
3 Years
-36.07%
13.1%
-19.9%

Highlights

Market Capitalization
5.6B
Book Value
$6.71
Earnings Per Share (EPS)
-0.07
PEG Ratio
3.22
Wall Street Target Price
16.73
Profit Margin
-1.44%
Operating Margin TTM
6.84%
Return On Assets TTM
2.85%
Return On Equity TTM
-1.21%
Revenue TTM
2.3B
Revenue Per Share TTM
5.51
Quarterly Revenue Growth YOY
10.7%
Gross Profit TTM
361.3M
EBITDA
538.3M
Diluted Eps TTM
-0.07
Quarterly Earnings Growth YOY
-0.99
EPS Estimate Current Year
-0.19
EPS Estimate Next Year
0.12
EPS Estimate Current Quarter
-0.01
EPS Estimate Next Quarter
-0.03

Analyst Recommendation

Buy
    73%Buy
    26%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for R1 Rcm Inc(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
15
19
Hold
5
4
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 24.57%

Current $13.43
Target $16.73

Company Financials

FY18Y/Y Change
Revenue
868.5M
↑ 93.09%
Net Income
-45.3M
↓ 22.96%
Net Profit Margin
-5.22%
↑ 7.85%
FY19Y/Y Change
Revenue
1.2B
↑ 36.57%
Net Income
12.0M
↓ 126.49%
Net Profit Margin
1.01%
↑ 6.23%
FY20Y/Y Change
Revenue
1.3B
↑ 7.14%
Net Income
115.2M
↑ 860.0%
Net Profit Margin
9.07%
↑ 8.06%
FY21Y/Y Change
Revenue
1.5B
↑ 16.04%
Net Income
87.3M
↓ 24.22%
Net Profit Margin
5.92%
↓ 3.15%
FY22Y/Y Change
Revenue
1.8B
↑ 22.5%
Net Income
-57.6M
↓ 165.98%
Net Profit Margin
-3.19%
↓ 9.11%
FY23Y/Y Change
Revenue
2.3B
↑ 24.79%
Net Income
3.3M
↓ 105.73%
Net Profit Margin
0.15%
↑ 3.34%
Q4 FY22Q/Q Change
Revenue
532.8M
↑ 7.42%
Net Income
-37.1M
↑ 25.76%
Net Profit Margin
-6.96%
↓ 1.01%
Q1 FY23Q/Q Change
Revenue
545.6M
↑ 2.4%
Net Income
300.0K
↓ 100.81%
Net Profit Margin
0.05%
↑ 7.01%
Q2 FY23Q/Q Change
Revenue
560.7M
↑ 2.77%
Net Income
300.0K
↑ 0.0%
Net Profit Margin
0.05%
↑ 0.0%
Q3 FY23Q/Q Change
Revenue
572.8M
↑ 2.16%
Net Income
1.3M
↑ 333.33%
Net Profit Margin
0.23%
↑ 0.18%
Q4 FY23Q/Q Change
Revenue
575.1M
↑ 0.4%
Net Income
1.4M
↑ 7.69%
Net Profit Margin
0.24%
↑ 0.01%
Q1 FY24Q/Q Change
Revenue
603.9M
↑ 5.01%
Net Income
-35.1M
↓ 2607.14%
Net Profit Margin
-5.81%
↓ 6.05%
FY18Y/Y Change
Total Assets
807.5M
↑ 140.33%
Total Liabilities
801.2M
↑ 164.77%
FY19Y/Y Change
Total Assets
929.1M
↑ 15.06%
Total Liabilities
911.0M
↑ 13.7%
FY20Y/Y Change
Total Assets
1.2B
↑ 27.97%
Total Liabilities
849.6M
↓ 6.74%
FY21Y/Y Change
Total Assets
1.4B
↑ 21.89%
Total Liabilities
1.1B
↑ 29.78%
FY22Y/Y Change
Total Assets
5.1B
↑ 254.64%
Total Liabilities
2.4B
↑ 119.42%
FY23Y/Y Change
Total Assets
5.0B
↓ 3.49%
Total Liabilities
2.2B
↓ 8.7%
Q4 FY22Q/Q Change
Total Assets
5.1B
↑ 1.16%
Total Liabilities
2.4B
↑ 4.58%
Q1 FY23Q/Q Change
Total Assets
5.1B
↓ 1.31%
Total Liabilities
2.4B
↓ 2.73%
Q2 FY23Q/Q Change
Total Assets
5.1B
↑ 0.03%
Total Liabilities
2.3B
↓ 0.93%
Q3 FY23Q/Q Change
Total Assets
5.1B
↓ 0.34%
Total Liabilities
2.3B
↓ 1.53%
Q4 FY23Q/Q Change
Total Assets
5.0B
↓ 1.91%
Total Liabilities
2.2B
↓ 3.78%
Q1 FY24Q/Q Change
Total Assets
5.8B
↑ 16.83%
Total Liabilities
3.0B
↑ 34.53%
FY18Y/Y Change
Operating Cash Flow
18.3M
↓ 12.44%
Investing Cash Flow
-496.3M
↑ 1377.08%
Financing Cash Flow
377.4M
↓ 9085.71%
FY19Y/Y Change
Operating Cash Flow
113.9M
↑ 522.4%
Investing Cash Flow
-61.0M
↓ 87.71%
Financing Cash Flow
-25.3M
↓ 106.7%
FY20Y/Y Change
Operating Cash Flow
61.8M
↓ 45.74%
Investing Cash Flow
-117.0M
↑ 91.8%
Financing Cash Flow
137.9M
↓ 645.06%
FY21Y/Y Change
Operating Cash Flow
264.8M
↑ 328.48%
Investing Cash Flow
-340.4M
↑ 190.94%
Financing Cash Flow
31.4M
↓ 77.23%
FY22Y/Y Change
Operating Cash Flow
-9.9M
↓ 103.74%
Investing Cash Flow
-949.5M
↑ 178.94%
Financing Cash Flow
943.0M
↑ 2903.18%
Q4 FY22Q/Q Change
Operating Cash Flow
29.6M
↑ 13.85%
Investing Cash Flow
-27.6M
↓ 13.48%
Financing Cash Flow
-22.5M
↓ 13.46%

Technicals Summary

Sell

Neutral

Buy

R1 Rcm Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
R1 Rcm Inc
R1 Rcm Inc
6.57%
27.61%
-19.14%
-36.07%
4.07%
Solventum Corp
Solventum Corp
5.52%
-21.66%
-21.66%
-21.66%
-21.66%
Veeva Systems Inc.
Veeva Systems Inc.
0.16%
-11.7%
-5.07%
-43.85%
12.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
3.02%
10.26%
0.74%
34.29%
34.29%
Healthequity Inc
Healthequity Inc
-8.8%
1.1%
20.74%
1.37%
-5.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
R1 Rcm Inc
R1 Rcm Inc
1152.8
NA
3.22
-0.19
-0.01
0.03
NA
6.71
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
54.06
54.06
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.45
23.45
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
79.76
79.76
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
R1 Rcm Inc
R1 Rcm Inc
Buy
$5.6B
4.07%
1152.8
-1.44%
Solventum Corp
Solventum Corp
Hold
$10.8B
-21.66%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.6B
12.83%
54.06
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.8B
34.29%
23.45
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.4B
-5.31%
79.76
7.71%

Insights on R1 Rcm Inc

  • Increasing Revenue

    Revenue is up for the last 9 quarters, 385.7M → 603.9M (in $), with an average increase of 5.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.4M → -35.1M (in $), with an average decrease of 2607.1% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 20.2% return, outperforming this stock by 43.4%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 1.4% return, outperforming this stock by 37.5%

Institutional Holdings

  • New Mountain Capital, L.L.C.

    22.41%
  • BlackRock Inc

    3.96%
  • Vanguard Group Inc

    3.58%
  • Coliseum Capital Management LLC

    2.44%
  • Voss Capital LLC

    2.19%
  • Bank of New York Mellon Corp

    1.28%

Company Information

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Organization
R1 Rcm Inc
Employees
29400
CEO
Mr. Lee Rivas
Industry
Health Services

FAQs